• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立和验证一种新型与过氧化物酶体相关的基因预后风险模型在肾透明细胞癌中的应用。

Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma.

机构信息

School of Stomatology, Henan University, Jinming Road, Kaifeng, Henan, 475000, China.

Department of Pediatric General Surgery, The Third Affiliated Hospital of Zhengzhou University, No. 7 Kangfu Qian Street, Zhengzhou, Henan, 450052, China.

出版信息

BMC Urol. 2024 Jan 31;24(1):26. doi: 10.1186/s12894-024-01404-z.

DOI:10.1186/s12894-024-01404-z
PMID:38297313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10829319/
Abstract

BACKGROUND

Kidney clear cell carcinoma (KIRC) is the most common subtype of renal cell carcinoma. Peroxisomes play a role in the regulation of tumorigenesis and cancer progression, yet the prognostic significance of peroxisome-related genes (PRGs) remains rarely studied. The study aimed to establish a novel prognostic risk model and identify potential biomarkers in KIRC.

METHODS

The significant prognostic PRGs were screened through differential and Cox regression analyses, and LASSO Cox regression analysis was performed to establish a prognostic risk model in the training cohort, which was validated internally in the testing and entire cohorts, and further assessed in the GSE22541 cohort. Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to explore the function and pathway differences between the high-risk and low-risk groups. The relationship between risk score and immune cell infiltration levels was evaluated in the CIBERSORT, ESTIMATE and TIMER databases. Finally, potential biomarkers were identified and validated from model genes, using immunohistochemistry.

RESULTS

Fourteen significant prognostic PRGs were identified using multiple analyses, and 9 genes (ABCD1, ACAD11, ACAT1, AGXT, DAO, EPHX2, FNDC5, HAO1, and HNGCLL1) were obtained to establish a prognostic model via LASSO Cox regression analysis. Combining the risk score with clinical factors to construct a nomogram, which provided support for personalized treatment protocols for KIRC patients. GO and KEGG analyses highlighted associations with substance metabolism, transport, and the PPAR signaling pathways. Tumor immune infiltration indicated immune suppression in the high-risk group, accompanied by higher tumor purity and the expression of 9 model genes was positively correlated with the level of immune cell infiltration. ACAT1 has superior prognostic capabilities in predicting the outcomes of KIRC patients.

CONCLUSIONS

The peroxisome-related prognostic risk model could better predict prognosis in KIRC patients.

摘要

背景

肾透明细胞癌(KIRC)是肾细胞癌中最常见的亚型。过氧化物酶体在肿瘤发生和癌症进展的调节中发挥作用,但过氧化物酶体相关基因(PRGs)的预后意义仍很少被研究。本研究旨在建立一种新的预后风险模型,并鉴定 KIRC 中的潜在生物标志物。

方法

通过差异和 Cox 回归分析筛选出有显著预后意义的 PRGs,在训练队列中进行 LASSO Cox 回归分析,建立预后风险模型,在测试队列和整个队列中进行内部验证,并在 GSE22541 队列中进行进一步评估。通过基因本体论(GO)富集和京都基因与基因组百科全书(KEGG)通路分析,探讨高危组和低危组之间的功能和通路差异。在 CIBERSORT、ESTIMATE 和 TIMER 数据库中评估风险评分与免疫细胞浸润水平的关系。最后,通过免疫组化从模型基因中鉴定和验证潜在的生物标志物。

结果

通过多分析鉴定出 14 个有显著预后意义的 PRGs,通过 LASSO Cox 回归分析得到 9 个基因(ABCD1、ACAD11、ACAT1、AGXT、DAO、EPHX2、FNDC5、HAO1 和 HNGCLL1)来建立预后模型。结合风险评分和临床因素构建列线图,为 KIRC 患者的个体化治疗方案提供支持。GO 和 KEGG 分析突出了与物质代谢、运输和过氧化物酶体增殖物激活受体信号通路的关联。肿瘤免疫浸润表明高危组存在免疫抑制,同时伴有更高的肿瘤纯度,9 个模型基因的表达与免疫细胞浸润水平呈正相关。ACAT1 具有预测 KIRC 患者预后的优越能力。

结论

过氧化物酶体相关预后风险模型可更好地预测 KIRC 患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/69038c1134e7/12894_2024_1404_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/5b3c0e48acf3/12894_2024_1404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/0655b0845e6c/12894_2024_1404_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/2db8e55b586a/12894_2024_1404_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/88204d6549fc/12894_2024_1404_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/1b24894e2b12/12894_2024_1404_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/496b9d310940/12894_2024_1404_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/b3c1f7526aca/12894_2024_1404_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/b0bd605810c4/12894_2024_1404_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/54ec4f9822ee/12894_2024_1404_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/da9b6ca812b9/12894_2024_1404_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/11b3795e05c5/12894_2024_1404_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/4eb6d521165b/12894_2024_1404_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/69038c1134e7/12894_2024_1404_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/5b3c0e48acf3/12894_2024_1404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/0655b0845e6c/12894_2024_1404_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/2db8e55b586a/12894_2024_1404_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/88204d6549fc/12894_2024_1404_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/1b24894e2b12/12894_2024_1404_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/496b9d310940/12894_2024_1404_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/b3c1f7526aca/12894_2024_1404_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/b0bd605810c4/12894_2024_1404_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/54ec4f9822ee/12894_2024_1404_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/da9b6ca812b9/12894_2024_1404_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/11b3795e05c5/12894_2024_1404_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/4eb6d521165b/12894_2024_1404_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1e/10829319/69038c1134e7/12894_2024_1404_Fig13_HTML.jpg

相似文献

1
Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma.建立和验证一种新型与过氧化物酶体相关的基因预后风险模型在肾透明细胞癌中的应用。
BMC Urol. 2024 Jan 31;24(1):26. doi: 10.1186/s12894-024-01404-z.
2
Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.LYSET 功能富集分析及相关枢纽基因特征的鉴定,作为预测透明细胞肾细胞癌预后和免疫浸润状态的新型生物标志物。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16905-16929. doi: 10.1007/s00432-023-05280-2. Epub 2023 Sep 23.
3
BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.BAG3 作为一种新型的肾透明细胞癌预后生物标志物与免疫浸润相关。
Eur J Med Res. 2024 Feb 1;29(1):93. doi: 10.1186/s40001-024-01687-w.
4
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.一种新型铁死亡相关的 12 基因标志物可预测透明细胞肾细胞癌的临床预后并揭示其免疫相关性。
BMC Cancer. 2021 Jul 19;21(1):831. doi: 10.1186/s12885-021-08559-0.
5
Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.上调的 PPP1R14B 与肾透明细胞癌的癌症进展和免疫浸润有关。
Clin Transl Oncol. 2024 Jan;26(1):119-135. doi: 10.1007/s12094-023-03228-z. Epub 2023 Jun 1.
6
Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.全面分析 MFN2 作为与肾透明细胞癌免疫细胞浸润相关的预后生物标志物。
Int Immunopharmacol. 2022 Oct;111:109169. doi: 10.1016/j.intimp.2022.109169. Epub 2022 Aug 22.
7
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.构建并验证自噬相关长非编码 RNA 标志物用于预测肾透明细胞癌患者的预后
Cancer Med. 2021 Apr;10(7):2359-2369. doi: 10.1002/cam4.3820. Epub 2021 Mar 2.
8
Peroxisome-related genes in hepatocellular carcinoma correlated with tumor metabolism and overall survival.肝细胞癌中与过氧化物酶体相关的基因与肿瘤代谢及总生存期相关。
Clin Res Hepatol Gastroenterol. 2022 Dec;46(10):101835. doi: 10.1016/j.clinre.2021.101835. Epub 2021 Nov 17.
9
Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.M7G 相关长链非编码 RNA 在肾透明细胞癌中的筛选及其潜在的诊断和预后作用。
BMC Urol. 2023 Nov 15;23(1):186. doi: 10.1186/s12894-023-01357-9.
10
A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.一个 miRNA-临床预后模型,用于预测肾透明细胞癌的总生存期。
Cancer Med. 2021 Sep;10(17):6128-6139. doi: 10.1002/cam4.4148. Epub 2021 Jul 21.

引用本文的文献

1
FNDC5 and ACOX1 as Biomarkers of Peroxisomal Activity with Contrast Outcomes in Colon Adenocarcinoma.FNDC5和ACOX1作为结肠腺癌中过氧化物酶体活性的生物标志物及对比结果
Biol Proced Online. 2025 Jul 23;27(1):27. doi: 10.1186/s12575-025-00289-y.
2
Identification and validation of a 9-RBPs-related gene signature associated with prognosis and immune infiltration in bladder cancer based on bioinformatics analysis and machine learning.基于生物信息学分析和机器学习的与膀胱癌预后及免疫浸润相关的9个RNA结合蛋白相关基因特征的鉴定与验证
Transl Androl Urol. 2025 Apr 30;14(4):1066-1081. doi: 10.21037/tau-2024-688. Epub 2025 Apr 27.
3

本文引用的文献

1
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma.肾细胞癌肿瘤微环境中的细胞与分子参与者
J Clin Med. 2023 Jun 7;12(12):3888. doi: 10.3390/jcm12123888.
2
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation.MUC1 表达通过补体系统激活和免疫浸润调节影响肾细胞癌微环境中的免疫炎症反应。
Int J Mol Sci. 2023 Mar 2;24(5):4814. doi: 10.3390/ijms24054814.
3
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets.
A Novel Peroxisome-Related Gene Signature Predicts Breast Cancer Prognosis and Correlates with T Cell Suppression.
一种新型的过氧化物酶体相关基因特征可预测乳腺癌预后并与T细胞抑制相关。
Breast Cancer (Dove Med Press). 2024 Dec 9;16:887-911. doi: 10.2147/BCTT.S490154. eCollection 2024.
4
Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer.构建包含铁死亡/铜死亡相关特征和突变景观分析的肌层浸润性膀胱癌预后模型。
BMC Cancer. 2024 Aug 6;24(1):958. doi: 10.1186/s12885-024-12741-5.
肾细胞癌作为一种代谢疾病:主要途径、潜在生物标志物和治疗靶点的最新研究进展。
Int J Mol Sci. 2022 Nov 18;23(22):14360. doi: 10.3390/ijms232214360.
4
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome.MUC1 组织表达及其可溶性形式 CA15-3 可识别出一种具有独特代谢特征和不良临床结局的透明细胞肾细胞癌。
Int J Mol Sci. 2022 Nov 12;23(22):13968. doi: 10.3390/ijms232213968.
5
The cross-talk between Abl2 tyrosine kinase and TGFβ1 signalling modulates the invasion of clear cell Renal Cell Carcinoma cells.Abl2 酪氨酸激酶与 TGFβ1 信号通路的串扰调节透明细胞肾细胞癌细胞的侵袭。
FEBS Lett. 2023 Apr;597(8):1098-1113. doi: 10.1002/1873-3468.14531. Epub 2022 Nov 15.
6
Hao1 Is Not a Pathogenic Factor for Ectopic Ossifications but Functions to Regulate the TCA Cycle In Vivo.Hao1不是异位骨化的致病因素,而是在体内发挥调节三羧酸循环的作用。
Metabolites. 2022 Jan 15;12(1):82. doi: 10.3390/metabo12010082.
7
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
8
Transcriptomic profiling of peroxisome-related genes reveals a novel prognostic signature in hepatocellular carcinoma.过氧化物酶体相关基因的转录组分析揭示了肝细胞癌一种新的预后特征。
Genes Dis. 2020 Apr 21;9(1):116-127. doi: 10.1016/j.gendis.2020.04.010. eCollection 2022 Jan.
9
Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy.鸢尾素在心肌梗死、心力衰竭和心肌肥厚中的作用。
Cells. 2021 Aug 16;10(8):2103. doi: 10.3390/cells10082103.
10
The Role of Irisin in Cancer Disease.鸢尾素在癌症疾病中的作用。
Cells. 2021 Jun 12;10(6):1479. doi: 10.3390/cells10061479.